Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Superconducting nanowire single photon detectors operating at temperature from 4 to 7 K.

Gourgues R, Los JWN, Zichi J, Chang J, Kalhor N, Bulgarini G, Dorenbos SN, Zwiller V, Zadeh IE.

Opt Express. 2019 Aug 19;27(17):24601-24609. doi: 10.1364/OE.27.024601.

PMID:
31510347
2.

Rapid gate-based spin read-out in silicon using an on-chip resonator.

Zheng G, Samkharadze N, Noordam ML, Kalhor N, Brousse D, Sammak A, Scappucci G, Vandersypen LMK.

Nat Nanotechnol. 2019 Aug;14(8):742-746. doi: 10.1038/s41565-019-0488-9. Epub 2019 Jul 8.

PMID:
31285611
3.

Micropapillary adenocarcinoma of lung: Morphological criteria and diagnostic reproducibility among pulmonary pathologists.

Monroig-Bosque PDC, Morales-Rosado JA, Roden AC, Churg A, Barrios R, Cagle P, Ge Y, Allen TC, Smith ML, Larsen BT, Sholl LM, Beasley MB, Borczuk A, Raparia K, Ayala A, Tazelaar HD, Miller R, Kalhor N, Moran CA, Ro JY.

Ann Diagn Pathol. 2019 Aug;41:43-50. doi: 10.1016/j.anndiagpath.2019.04.008. Epub 2019 Apr 24.

PMID:
31132651
4.

Development and Validation of a Pathology Image Analysis-based Predictive Model for Lung Adenocarcinoma Prognosis - A Multi-cohort Study.

Luo X, Yin S, Yang L, Fujimoto J, Yang Y, Moran C, Kalhor N, Weissferdt A, Xie Y, Gazdar A, Minna J, Wistuba II, Mao Y, Xiao G.

Sci Rep. 2019 May 3;9(1):6886. doi: 10.1038/s41598-019-42845-z.

5.

Driver Mutations in Normal Airway Epithelium Elucidate Spatiotemporal Resolution of Lung Cancer.

Kadara H, Sivakumar S, Jakubek Y, San Lucas FA, Lang W, McDowell T, Weber Z, Behrens C, Davies GE, Kalhor N, Moran C, El-Zein R, Mehran R, Swisher SG, Wang J, Zhang J, Fujimoto J, Fowler J, Heymach JV, Dubinett S, Spira AE, Ehli EA, Wistuba II, Scheet P.

Am J Respir Crit Care Med. 2019 Sep 15;200(6):742-750. doi: 10.1164/rccm.201806-1178OC.

PMID:
30896962
6.

Revisiting localized malignant mesothelioma.

Mann S, Khawar S, Moran C, Kalhor N.

Ann Diagn Pathol. 2019 Apr;39:74-77. doi: 10.1016/j.anndiagpath.2019.02.014. Epub 2019 Feb 19. Review.

PMID:
30798074
7.

Thymic epithelial neoplasms with sebaceous differentiation: a clinicopathological and immunohistochemical study of 8 cases.

Kalhor N, Moran CA.

Hum Pathol. 2019 Apr;86:124-128. doi: 10.1016/j.humpath.2018.11.030. Epub 2018 Dec 8.

PMID:
30537491
8.

Osteoclast-like giant cell-rich carcinomas of the lung: a clinicopathological, immunohistochemical, and molecular study of 3 cases.

Lindholm KE, Kalhor N, Moran CA.

Hum Pathol. 2019 Mar;85:168-173. doi: 10.1016/j.humpath.2018.10.030. Epub 2018 Nov 14.

PMID:
30447297
9.

Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of RICTOR/KRAS-altered non-small cell lung cancer.

Ruder D, Papadimitrakopoulou V, Shien K, Behrens C, Kalhor N, Chen H, Shen L, Lee JJ, Hong WK, Tang X, Girard L, Minna JD, Diao L, Wang J, Mino B, Villalobos P, Rodriguez-Canales J, Hanson NE, Sun J, Miller V, Greenbowe J, Frampton G, Herbst RS, Baladandayuthapani V, Wistuba II, Izzo JG.

Oncotarget. 2018 Sep 21;9(74):33995-34008. doi: 10.18632/oncotarget.26129. eCollection 2018 Sep 21.

10.

Thymomas With a Prominent Alveolar Growth Pattern: A Clinicopathologic and Immunohistochemical Study of 12 Cases.

Kalhor N, Moran CA.

Am J Clin Pathol. 2019 Jan 7;151(2):171-175. doi: 10.1093/ajcp/aqy127.

PMID:
30247496
11.

Incorporation of Cervista Human Papillomavirus 16/18 Assay Into Algorithms for Classifying Human Papillomavirus Status in Formalin-Fixed, Paraffin-Embedded Head and Neck Squamous Carcinoma Specimens.

Guo M, Khanna A, Wang J, Williams MD, Kalhor N, Gong Y, Xu L, Sturgis EM, Staerkel G.

Arch Pathol Lab Med. 2019 Mar;143(3):356-361. doi: 10.5858/arpa.2017-0469-OA. Epub 2018 Sep 17.

PMID:
30221979
12.

Thymic epithelial neoplasms with rhabdomyomatous component: a clinicopathological and immunohistochemical study of 7 cases.

Kalhor N, Moran CA.

Hum Pathol. 2019 Jan;83:100-105. doi: 10.1016/j.humpath.2018.08.027. Epub 2018 Sep 12.

PMID:
30217623
13.

Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches.

Parra ER, Villalobos P, Behrens C, Jiang M, Pataer A, Swisher SG, William WN Jr, Zhang J, Lee J, Cascone T, Heymach JV, Forget MA, Haymaker C, Bernatchez C, Kalhor N, Weissferdt A, Moran C, Zhang J, Vaporciyan A, Gibbons DL, Sepesi B, Wistuba II.

J Immunother Cancer. 2018 Jun 6;6(1):48. doi: 10.1186/s40425-018-0368-0.

14.

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.

Skoulidis F, Goldberg ME, Greenawalt DM, Hellmann MD, Awad MM, Gainor JF, Schrock AB, Hartmaier RJ, Trabucco SE, Gay L, Ali SM, Elvin JA, Singal G, Ross JS, Fabrizio D, Szabo PM, Chang H, Sasson A, Srinivasan S, Kirov S, Szustakowski J, Vitazka P, Edwards R, Bufill JA, Sharma N, Ou SI, Peled N, Spigel DR, Rizvi H, Aguilar EJ, Carter BW, Erasmus J, Halpenny DF, Plodkowski AJ, Long NM, Nishino M, Denning WL, Galan-Cobo A, Hamdi H, Hirz T, Tong P, Wang J, Rodriguez-Canales J, Villalobos PA, Parra ER, Kalhor N, Sholl LM, Sauter JL, Jungbluth AA, Mino-Kenudson M, Azimi R, Elamin YY, Zhang J, Leonardi GC, Jiang F, Wong KK, Lee JJ, Papadimitrakopoulou VA, Wistuba II, Miller VA, Frampton GM, Wolchok JD, Shaw AT, Jänne PA, Stephens PJ, Rudin CM, Geese WJ, Albacker LA, Heymach JV.

Cancer Discov. 2018 Jul;8(7):822-835. doi: 10.1158/2159-8290.CD-18-0099. Epub 2018 May 17.

16.

Correlation of CD81 and SCARB1 polymorphisms on virological responses in Iranian patients with chronic hepatitis C virus genotype 1.

Nafari M, Irani S, Vaziri F, Gharibzadeh S, Sakhaee F, Khazeni M, Kalhor N, Jamnani FR, Siadat SD, Fateh A.

Infect Genet Evol. 2018 Aug;62:296-303. doi: 10.1016/j.meegid.2018.04.038. Epub 2018 Apr 30.

PMID:
29715527
17.

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.

Kadara H, Choi M, Zhang J, Parra ER, Rodriguez-Canales J, Gaffney SG, Zhao Z, Behrens C, Fujimoto J, Chow C, Yoo Y, Kalhor N, Moran C, Rimm D, Swisher S, Gibbons DL, Heymach J, Kaftan E, Townsend JP, Lynch TJ, Schlessinger J, Lee J, Lifton RP, Wistuba II, Herbst RS.

Ann Oncol. 2018 Apr 1;29(4):1072. doi: 10.1093/annonc/mdx062. No abstract available.

PMID:
29688333
18.

Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer.

Gomez DR, Byers LA, Nilsson M, Diao L, Wang J, Li L, Tong P, Hofstad M, Saigal B, Wistuba I, Kalhor N, Swisher S, Fan Y, Hong WK, Suraokar M, Behrens C, Moran C, Heymach JV.

Oncotarget. 2018 Jan 30;9(18):14268-14284. doi: 10.18632/oncotarget.24361. eCollection 2018 Mar 6.

19.

MET amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancer.

Fang L, Chen H, Tang Z, Kalhor N, Liu CH, Yao H, Hu S, Lin P, Zhao J, Luthra R, Singh RR, Routbort MJ, Hong D, Medeiros LJ, Lu X.

Oncotarget. 2018 Feb 7;9(16):12959-12970. doi: 10.18632/oncotarget.24430. eCollection 2018 Feb 27.

20.

Immunohistochemical and Image Analysis-Based Study Shows That Several Immune Checkpoints are Co-expressed in Non-Small Cell Lung Carcinoma Tumors.

Parra ER, Villalobos P, Zhang J, Behrens C, Mino B, Swisher S, Sepesi B, Weissferdt A, Kalhor N, Heymach JV, Moran C, Zhang J, Lee J, Rodriguez-Canales J, Gibbons D, Wistuba II.

J Thorac Oncol. 2018 Jun;13(6):779-791. doi: 10.1016/j.jtho.2018.03.002. Epub 2018 Mar 8.

21.

Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations.

Noll B, Wang WL, Gong Y, Zhao J, Kalhor N, Prieto V, Staerkel G, Roy-Chowdhuri S.

Cancer Cytopathol. 2018 May;126(5):342-352. doi: 10.1002/cncy.21987. Epub 2018 Mar 2.

22.

Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancer.

Lee WC, Diao L, Wang J, Zhang J, Roarty EB, Varghese S, Chow CW, Fujimoto J, Behrens C, Cascone T, Peng W, Kalhor N, Moran CA, Weissferdt A, Johnson FM, William WN Jr, Swisher SG, Lee JJ, Hong WK, Heymach JV, Wistuba II, Futreal PA, Zhang J.

Mod Pathol. 2018 Jun;31(6):947-955. doi: 10.1038/s41379-018-0029-3. Epub 2018 Feb 6.

23.

Strong spin-photon coupling in silicon.

Samkharadze N, Zheng G, Kalhor N, Brousse D, Sammak A, Mendes UC, Blais A, Scappucci G, Vandersypen LMK.

Science. 2018 Mar 9;359(6380):1123-1127. doi: 10.1126/science.aar4054. Epub 2018 Jan 25.

PMID:
29371427
24.

Primary thymic adenocarcinomas: a clinicopathological and immunohistochemical study of 16 cases with emphasis on the morphological spectrum of differentiation.

Kalhor N, Moran CA.

Hum Pathol. 2018 Apr;74:73-82. doi: 10.1016/j.humpath.2018.01.011. Epub 2018 Jan 12.

PMID:
29339175
25.

Pulmonary mucoepidermoid carcinoma: diagnosis and treatment.

Kalhor N, Moran CA.

Expert Rev Respir Med. 2018 Mar;12(3):249-255. doi: 10.1080/17476348.2018.1428563. Epub 2018 Jan 17. Review.

PMID:
29338644
26.

Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer.

Cascone T, Gold KA, Swisher SG, Liu DD, Fossella FV, Sepesi B, Pataer A, Weissferdt A, Kalhor N, Vaporciyan AA, Hofstetter WL, Wistuba II, Heymach JV, Kim ES, William WN Jr.

Ann Thorac Surg. 2018 Feb;105(2):418-424. doi: 10.1016/j.athoracsur.2017.08.052. Epub 2017 Dec 6.

27.

Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer.

Sepesi B, Cuentas EP, Canales JR, Behrens C, Correa AM, Vaporciyan A, Weissferdt A, Kalhor N, Moran C, Swisher S, Wistuba I.

Semin Thorac Cardiovasc Surg. 2017 Autumn;29(3):408-415. doi: 10.1053/j.semtcvs.2017.05.008. Epub 2017 May 26.

PMID:
29195578
28.

Thymoma: a clinicopathological correlation of 1470 cases.

Weissferdt A, Kalhor N, Bishop JA, Jang SJ, Ro J, Petersson F, Wu B, Langman G, Bancroft H, Bi Y, Meng Y, Medeiros F, Brunnstrom H, Spagnolo D, Chai SM, Laycock A, Wakely PE Jr, Elmberger G, Soares FA, Campos AH, Gumurdulu D, Alvarado-Cabrero I, Coppola D, Correa AM, Rice D, Mehran RJ, Sepesi B, Walsh G, Kaiser L, Moran CA.

Hum Pathol. 2018 Mar;73:7-15. doi: 10.1016/j.humpath.2017.08.018. Epub 2017 Aug 26.

PMID:
28851660
29.

Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial.

Khoury JD, Wang WL, Prieto VG, Medeiros LJ, Kalhor N, Hameed M, Broaddus R, Hamilton SR.

Clin Cancer Res. 2018 Feb 1;24(3):521-531. doi: 10.1158/1078-0432.CCR-17-1597. Epub 2017 Aug 24. Review.

30.

JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung Cancer.

Shien K, Papadimitrakopoulou VA, Ruder D, Behrens C, Shen L, Kalhor N, Song J, Lee JJ, Wang J, Tang X, Herbst RS, Toyooka S, Girard L, Minna JD, Kurie JM, Wistuba II, Izzo JG.

Mol Cancer Ther. 2017 Oct;16(10):2234-2245. doi: 10.1158/1535-7163.MCT-17-0148. Epub 2017 Jul 20.

31.

Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients.

Wadhwa R, Wang X, Baladandayuthapani V, Liu B, Shiozaki H, Shimodaira Y, Lin Q, Elimova E, Hofstetter WL, Swisher SG, Rice DC, Maru DM, Kalhor N, Bhutani MS, Weston B, Lee JH, Skinner HD, Scott AW, Kaya DM, Harada K, Berry D, Song S, Ajani JA.

Br J Cancer. 2017 Aug 22;117(5):648-655. doi: 10.1038/bjc.2017.225. Epub 2017 Jul 20.

32.

Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing Radiotherapy.

Adams DL, Adams DK, He J, Kalhor N, Zhang M, Xu T, Gao H, Reuben JM, Qiao Y, Komaki R, Liao Z, Edelman MJ, Tang CM, Lin SH.

Clin Cancer Res. 2017 Oct 1;23(19):5948-5958. doi: 10.1158/1078-0432.CCR-17-0802. Epub 2017 Jul 5.

33.

Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors.

Dalvi MP, Wang L, Zhong R, Kollipara RK, Park H, Bayo J, Yenerall P, Zhou Y, Timmons BC, Rodriguez-Canales J, Behrens C, Mino B, Villalobos P, Parra ER, Suraokar M, Pataer A, Swisher SG, Kalhor N, Bhanu NV, Garcia BA, Heymach JV, Coombes K, Xie Y, Girard L, Gazdar AF, Kittler R, Wistuba II, Minna JD, Martinez ED.

Cell Rep. 2017 May 23;19(8):1669-1684. doi: 10.1016/j.celrep.2017.04.077.

34.

Radiation-induced Angiosarcoma as a Cause of Pleural Effusion.

Miller R, Mudambi L, Vial MR, Kalhor N, Grosu HB.

Am J Respir Crit Care Med. 2017 Aug 15;196(4):e10-e11. doi: 10.1164/rccm.201702-0442IM. No abstract available.

PMID:
28510475
35.

Cutaneous basal cell carcinoma with distant metastasis to thorax and bone : A clinicopathological and immunohistochemical study of 15 cases.

Weissferdt A, Kalhor N, Moran CA.

Virchows Arch. 2017 Jun;470(6):687-694. doi: 10.1007/s00428-017-2121-3. Epub 2017 Apr 8.

PMID:
28391557
36.

Clinicopathologic and genetic features of primary bronchopulmonary mucoepidermoid carcinoma: the MD Anderson Cancer Center experience and comprehensive review of the literature.

Salem A, Bell D, Sepesi B, Papadimitrakopoulou V, El-Naggar A, Moran CA, Kalhor N.

Virchows Arch. 2017 Jun;470(6):619-626. doi: 10.1007/s00428-017-2104-4. Epub 2017 Mar 25. Review.

PMID:
28343305
37.

Expression of PD-1 and PD-L1 in thymic epithelial neoplasms.

Weissferdt A, Fujimoto J, Kalhor N, Rodriguez J, Bassett R, Wistuba II, Moran CA.

Mod Pathol. 2017 Jun;30(6):826-833. doi: 10.1038/modpathol.2017.6. Epub 2017 Mar 10.

38.

Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function.

Choi M, Kadara H, Zhang J, Parra ER, Rodriguez-Canales J, Gaffney SG, Zhao Z, Behrens C, Fujimoto J, Chow C, Kim K, Kalhor N, Moran C, Rimm D, Swisher S, Gibbons DL, Heymach J, Kaftan E, Townsend JP, Lynch TJ, Schlessinger J, Lee J, Lifton RP, Herbst RS, Wistuba II.

Ann Oncol. 2017 Jan 1;28(1):83-89. doi: 10.1093/annonc/mdw437.

39.

"Sarcomatoid" carcinomas of the lung: a clinicopathological study of 86 cases with a new perspective on tumor classification.

Weissferdt A, Kalhor N, Correa AM, Moran CA.

Hum Pathol. 2017 May;63:14-26. doi: 10.1016/j.humpath.2016.12.010. Epub 2016 Dec 16.

PMID:
27993578
40.

Primary Salivary Gland Type Tumors of the Thymus.

Kalhor N, Weissferdt A, Moran CA.

Adv Anat Pathol. 2017 Jan;24(1):15-23. Review.

PMID:
27941539
41.

Pleuromediastinal Epithelial-Myoepithelial Carcinomas: A Clinicopathologic and Immunohistochemical Study of Two Cases.

Weissferdt A, Kalhor N, Moran CA.

Am J Clin Pathol. 2016 Dec;146(6):736-740. doi: 10.1093/ajcp/aqw199. Epub 2016 Nov 17.

PMID:
27864182
42.
43.

Ectopic Hamartomatous Thymoma-New Insights Into a Challenging Entity: A Clinicopathologic and Immunohistochemical Study of 9 Cases.

Weissferdt A, Kalhor N, Petersson F, Moran CA.

Am J Surg Pathol. 2016 Nov;40(11):1571-1576.

PMID:
27428736
44.

Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer.

Wang J, Kalhor N, Hu J, Wang B, Chu H, Zhang B, Guan Y, Wu Y.

PLoS One. 2016 Oct 3;11(10):e0163397. doi: 10.1371/journal.pone.0163397. eCollection 2016.

45.

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.

Kadara H, Choi M, Zhang J, Parra ER, Rodriguez-Canales J, Gaffney SG, Zhao Z, Behrens C, Fujimoto J, Chow C, Yoo Y, Kalhor N, Moran C, Rimm D, Swisher S, Gibbons DL, Heymach J, Kaftan E, Townsend JP, Lynch TJ, Schlessinger J, Lee J, Lifton RP, Wistuba II, Herbst RS.

Ann Oncol. 2017 Jan 1;28(1):75-82. doi: 10.1093/annonc/mdw436. Erratum in: Ann Oncol. 2018 Apr 1;29(4):1072.

46.

Primary Mediastinal Yolk Sac Tumors: An Immunohistochemical Analysis of 14 Cases.

Weissferdt A, Kalhor N, Rodriguez Canales J, Fujimoto J, Wistuba II, Moran CA.

Appl Immunohistochem Mol Morphol. 2019 Feb;27(2):125-133. doi: 10.1097/PAI.0000000000000442.

PMID:
27643524
47.

Spindle cell and pleomorphic ("sarcomatoid") carcinomas of the lung: an immunohistochemical analysis of 86 cases.

Weissferdt A, Kalhor N, Rodriguez Canales J, Fujimoto J, Wistuba II, Moran CA.

Hum Pathol. 2017 Jan;59:1-9. doi: 10.1016/j.humpath.2016.08.003. Epub 2016 Aug 25.

PMID:
27569293
48.

The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer.

Papadimitrakopoulou V, Lee JJ, Wistuba II, Tsao AS, Fossella FV, Kalhor N, Gupta S, Byers LA, Izzo JG, Gettinger SN, Goldberg SB, Tang X, Miller VA, Skoulidis F, Gibbons DL, Shen L, Wei C, Diao L, Peng SA, Wang J, Tam AL, Coombes KR, Koo JS, Mauro DJ, Rubin EH, Heymach JV, Hong WK, Herbst RS.

J Clin Oncol. 2016 Oct 20;34(30):3638-3647. doi: 10.1200/JCO.2015.66.0084.

49.

Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis.

Padanad MS, Konstantinidou G, Venkateswaran N, Melegari M, Rindhe S, Mitsche M, Yang C, Batten K, Huffman KE, Liu J, Tang X, Rodriguez-Canales J, Kalhor N, Shay JW, Minna JD, McDonald J, Wistuba II, DeBerardinis RJ, Scaglioni PP.

Cell Rep. 2016 Aug 9;16(6):1614-1628. doi: 10.1016/j.celrep.2016.07.009. Epub 2016 Jul 28.

50.

Sebaceous lymphadenoma of the thymus: A clinicopathologic and immunohistochemical study of 2 cases.

Weissferdt A, Kalhor N, Moran CA.

Hum Pathol. 2016 Oct;56:189-93. doi: 10.1016/j.humpath.2016.06.015. Epub 2016 Jun 29.

PMID:
27374279

Supplemental Content

Loading ...
Support Center